Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Sukumar Mukherjee"'
Autor:
Keerthi Talari, Vinod Ravindran, Pradip Kumar, Pravin Patil, Sarath Chandra Mouli, Syamasis Bandyopadhyay, Balebail G Dharmanand, Abhrajit Ray, Shankaralingam Rajeshwari, Sanjiv N Amin, Jyotsna Oak, Ved Chaturvedi, Anand N Malaviya, Sukumar Mukherjee
Publikováno v:
Indian Journal of Rheumatology, Vol 16, Iss 3, Pp 311-321 (2021)
Pharmacological management of rheumatoid arthritis (RA) includes synthetic and biological disease-modifying antirheumatic drugs (DMARDs). Biological DMARDs, also referred to as “biologics,” rapidly retard progression of the joint damage seen in R
Externí odkaz:
https://doaj.org/article/8afbed8558ee4037a7ddc3fa0f34c61f
Autor:
Sarath Chandra Mouli, Keerthi Talari, Abhrajit Ray, Syamasis Bandyopadhyay, Balebail G. Dharmanand, Anand N. Malaviya, Shankaralingam Rajeshwari, Sanjiv Amin, Sukumar Mukherjee, Pradip Kumar, Pravin Patil, Vinod Ravindran, V K Chaturvedi, Jyotsna Oak
Publikováno v:
Indian Journal of Rheumatology, Vol 16, Iss 3, Pp 311-321 (2021)
Pharmacological management of rheumatoid arthritis (RA) includes synthetic and biological disease-modifying antirheumatic drugs (DMARDs). Biological DMARDs, also referred to as “biologics,” rapidly retard progression of the joint damage seen in R
Publikováno v:
The Indian Journal of Medical Research
Indian Journal of Medical Research, Vol 152, Iss 5, Pp 456-467 (2020)
Indian Journal of Medical Research, Vol 152, Iss 5, Pp 456-467 (2020)
Biosimilars or similar biotherapeutic products are the biological products approved by regulatory agencies based on the demonstration of similarity in quality, safety and efficacy with reference biologics (or original biologics). Though biosimilars c